Highlights
- 1JAMA health forum · 2025
- 2
- 3
Publications
24 publications
Funding
9 grantsView NIH portfolio on RePORTER ↗
Active
9 grants- PIK01AG092905-01A1Major pharmacy chain and retailer investments in primary care and implications for access to and quality of care in older adultsNational Institute on Aging · 2026–2030
- Sub-PIP01AG032952-17Medicare at a Crossroads - Project 3National Institute on Aging · 2025–2030 · via Harvard University· 2 renewals
- Co-INU58DP007916-01-00Bridging Gaps and Transforming CARE for Young Breast Cancer Survivors and those with Metastatic DiseaseCenters for Disease Control and Prevention · 2024–2029No publications yet
- Co-IPF 255784-01The Physicians Foundation Center for the Study of Physician Practice and Leadership at Weill CornellPhysicians Foundation, Inc. · 2026–2029
- PI25-15693The impact of the Inflation Reduction Act (IRA) on the launch prices of new medicinesArnold Ventures · 2025–2027
- PIPCH 26092Improving efficiency in US health care by leveraging patients' revealed preferences for hospitalsPeterson Center on Healthcare · 2025–2027
- PI24-24475Skirting the Medical-Loss-Ratio with Vertical Integration: Do Medicare Prescription Drug Plans Overpay Their Own Pharmacies?Commonwealth Fund · 2025–2027
- Sub-PINIHCM 254513-01Quantifying Growth in Provider Margins in Cancer DrugsNIH Care Management Research and Educational Foundation · 2026–2026 · via Memorial Sloan Kettering Cancer Center
- Sub-PIR01CA255035-03S2The Impact of a Changing Health Care Delivery System on the Quality of Oncology Care - Administrative SupplementNational Cancer Institute · 2022–2025 · via Harvard University
Clinical research
5 studies
Active
1 study- PIMajor pharmacy chain and retailer investments in primary care and implications for access to and quality of care in older adultsWeill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2025)
Completed & closed trials (4)
- PIPoint-of-sale denials at retail pharmacies and implications for equitable access to medicationsWeill Medical College of Cornell University · IRB STUDY CLOSURE (as of 2026)
- PIExamining the health plan, provider, and patient factors influencing access, affordability, and value in the use of prescription drugs for Medicare beneficiariesWeill Medical College of Cornell University · CLOSED TO ACCRUAL (as of 2025)
- PIImpact of a Changing Health Care Delivery System on the Quality of Oncology CareWeill Medical College of Cornell University · CLOSED TO ACCRUAL (as of 2024)
- PIImpact of changes in the organization of pharmacy services on the use of prescription medicationsWeill Medical College of Cornell University · CLOSED TO ACCRUAL (as of 2024)
News mentions
3 mentionsView all WCM news ↗
- Should Medicaid Tie Drug Prices To What Other Countries Pay?May 2, 2026
A pilot program aimed at reducing Medicaid drug spending has limitations, according to a multi-institutional research team including faculty from Weill Cornell Medicine.
- Medicare Rules May Reduce Prescription SteeringJanuary 10, 2025
Weill Cornell Medicine researchers have found that pharmacy benefit managers (PBMs)—organizations that negotiate access to medicines for most patients in the United States—steer patients to use their own pharmacies.
- Revising Medicare Part D Prescription Drug Policy Could Save BillionsOctober 7, 2024
Researchers have found that removing protected class regulation from Medicare prescription drug policies could greatly reduce the United States' prescription drug spending—this could have saved potentially $47 billion between 2011-2019.
External relationships
Other Interest
National Bureau of Economic Research